Benzinga's Top Initiations

Analysts at Goldman Sachs initiated coverage on shares of Verisk Analytics

with a “neutral” rating. The target price for Verisk Analytics is set to $68. Verisk Analytics' shares closed at $66.39 yesterday. JP Morgan initiated coverage on shares of NPS Pharmaceuticals

with an “overweight” rating. The target price for NPS Pharmaceuticals is set to $40. NPS Pharmaceuticals' shares closed at $29.01 yesterday. Credit Suisse initiated coverage on shares of Macerich Company (The)

with an “underperform” rating. The target price for Macerich Company is set to $58. Macerich's stock closed at $59.61 yesterday. Analysts at Citigroup initiated coverage on shares of Clovis Oncology

with a “buy” rating. The target price for Clovis Oncology is set to $109. Clovis Oncology's shares closed at $75.23 yesterday.